Administration of Vitamin K to Newborn Infants

NY-ADR

3/12/14 N.Y. St. Reg. HLT-36-13-00002-A
NEW YORK STATE REGISTER
VOLUME XXXVI, ISSUE 10
March 12, 2014
RULE MAKING ACTIVITIES
DEPARTMENT OF HEALTH
NOTICE OF ADOPTION
 
I.D No. HLT-36-13-00002-A
Filing No. 156
Filing Date. Feb. 25, 2014
Effective Date. s , 90 d
Administration of Vitamin K to Newborn Infants
PURSUANT TO THE PROVISIONS OF THE State Administrative Procedure Act, NOTICE is hereby given of the following action:
Action taken:
Amendment of section 12.3 of Title 10 NYCRR.
Statutory authority:
Public Health Law, section 225
Subject:
Administration of Vitamin K to Newborn Infants.
Purpose:
Requires Vitamin K administration to newborn infants to be consistent w/2012 American Academy of Pediatrics' Policy Statement.
Text or summary was published
in the September 4, 2013 issue of the Register, I.D. No. HLT-36-13-00002-P.
Final rule as compared with last published rule:
No changes.
Text of rule and any required statements and analyses may be obtained from:
Katherine Ceroalo, DOH, Bureau of House Counsel, Reg. Affairs Unit, Room 2438, ESP Tower Building, Albany, NY 12237, (518) 473-7488, email: [email protected]
Assessment of Public Comment
Public comments were submitted to the NYS Department of Health (DOH) in response to the regulation. The public comment period for this regulation ended on October 21, 2013. The Department received a total of nine comments from representatives of the provider community including private medical practitioners, the Academy of Breastfeeding Medicine, and the University at Albany School of Public Health.
Eight of the nine comments were similar and positive, stating that the adoption of these regulations is an obvious benefit to mother-newborn bonding. Summarized below is the Department of Health’s response to the one comment that was not supportive:
COMMENT: One commenter cited and enclosed an article from the AAP News December 2008; 29(12). This is a newsletter of the American Academy of Pediatrics (AAP), and not a peer-reviewed journal. The newsletter usually summarizes other publications or policies, though no references are included. As the commenter pointed out, in this issue of AAP News, an article Creating protocols for transitional care of the healthy, term newborn, states:
Vitamin K – Within the first hour of delivery, give a single parental dose of natural vitamin K1 oxide (phytonadione) (0.5-1 mg) to prevent vitamin K-dependent hemorrhagic disease.
RESPONSE: The purpose of the proposed regulation change is to make it consistent with the more recent policy statement, issued in 2012, by the American Academy of Pediatrics (AAP): Policy Statement: Breastfeeding and the Use of Human Milk. Pediatrics 2012; 129:e827. (accessed 12/13/2012 at: pediatrics.aappublications.org/content/129/3/e827.full.html). This statement specifically recommends a delay in administration of intramuscular vitamin K until after the first feeding is completed, but within 6 hours of birth,” and a delay in routine procedures (weighing, measuring, bathing, blood tests, vaccines, and eye prophylaxis) until after the first feeding is completed.
The more recent AAP Policy Statement recommendations (2012) should take precedence over the earlier AAP News article (2008).
End of Document